查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1588499

蛋白质表现市场规模、份额、成长分析、按产品和服务、按系统类型、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Protein Expression Market Size, Share, Growth Analysis, By Product and Service, By System Type, By Application, By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 209 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球蛋白表现市场规模为29亿美元，从2023年的32.9亿美元成长到2031年的89.2亿美元，预计复合年增长率为13.3%。

由于生物技术进步推动治疗应用重组蛋白的需求不断增加，蛋白表现市场正经历快速成长。个人化医疗的兴起进一步加速了对客製化蛋白质疗法的需求。蛋白质工程和重组蛋白人工生产的持续研究和开发正在推动市场进步。此外，蛋白质表现的创新为透过个人化治疗改善患者护理提供了新的机会。透过与市场参与者和学术机构的策略联盟，促进桿状病毒和瞬时表达系统等最尖端科技的开发，从而促进市场扩张。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 价格分析
  • 技术分析
  • 专利分析
  • 价值链分析
  • 供应链分析
  • 客户和购买标准分析
  • 监管分析

蛋白质表现市场：依产品/服务分类

  • 市场概况
  • 试剂
  • 表达载体
  • 胜任细胞
  • 装置
  • 服务

蛋白质表现市场：依系统类型

  • 市场概况
  • 哺乳动物细胞表现系统
    • 中国仓鼠卵巢细胞系统（Cho细胞系统）
    • 人类胎儿肾细胞系统（Hek 293细胞系统）
    • 其他哺乳动物细胞株
  • 原核表达系统
    • 大肠桿菌系统
    • 其他原核表达系统
  • 昆虫细胞表现系统
    • 桿状病毒系统
    • 其他昆虫细胞系统
  • 酵母表现系统
    • 毕赤酵母系统
    • 酵母系统
    • 其他酵母表现系统
  • 无细胞表现系统
  • 基于藻类的表达系统

蛋白质表现市场：依应用分类

  • 市场概况
  • 治疗用途
  • 研究用途
  • 工业用途

蛋白质表现市场：依最终用户分类

  • 市场概况
  • 製药和生物技术公司
  • 学术研究所
  • 受託研究机构以及合约开发和製造组织（CROS 和 CDMO）
  • 其他最终用户

蛋白质表现市场：按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率（2023年）

主要企业简介

  • Thermo Fisher Scientific, Inc.（US）
  • Merck KGaA（Germany）
  • Genscript Biotech Corporation（China）
  • Agilent Technologies Inc.（US）
  • Takara Bio, Inc.（Japan）
  • Bio-Rad Laboratories, Inc.（US）
  • Qiagen NV（Netherlands）
  • Charles River Laboratories International, Inc.（US）
  • Danaher Corporation（US）
  • Sartorius AG（Germany）
  • Corning Incorporated（US）
  • Fujifilm Irvine Scientific, Inc.（Acquired by Fujifilm Holdings Corporation）（US）
  • Lonza Group AG（Switzerland）
  • Bioneer Corporation（South Korea）
  • Promega Corporation（US）
  • Oxford Expression Technologies Ltd.（UK）
  • Proteogenix（France）
  • Abeomics Inc.（US）
  • New England Biolabs, Inc.（US）
  • Promab Biotechnologies（US）
  • Sino Biological, Inc.（China）
  • Jena Bioscience（Germany）
  • Lifesensors, Inc.（US）
  • Leading Biology, Inc.（US）
  • Peak Proteins（UK）
简介目录
Product Code: SQMIG35H2291

Global Protein Expression Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.29 billion in 2023 to USD 8.92 billion by 2031, growing at a CAGR of 13.3% in the forecast period (2024-2031).

The protein expression market is experiencing rapid growth due to the increasing demand for recombinant proteins in therapeutic applications, fueled by advancements in biotechnology. The rise of personalized medicine has further accelerated the need for customized protein-based therapies. Ongoing research and development in protein engineering and the artificial production of recombinant proteins are driving market progress. Additionally, technological innovations in protein expression are opening new opportunities to improve patient care through personalized treatments. Strategic collaborations between market players and academic institutions are fostering the development of cutting-edge technologies, including baculovirus and transient expression systems, boosting market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Expression market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Expression Market Segmental Analysis

Global Protein Expression Market is segmented on the product & service, system type, application, end user, and region. By product and service, the market is segmented into Reagents, Expression Vectors, Competent Cells, Instruments, and Services. By system type, the market is segmented into Mammalian Cell Expression Systems, Prokaryotic Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, and Algal-Based Expression Systems. By application, the market is segmented into Therapeutic Applications, Research Applications, and Industrial Applications. By end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations & Contract Development and Manufacturing Organizations (CROs & CDMOs), and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Protein Expression Market

The protein expression market is experiencing significant growth, driven by the widespread use of E. coli bacteria for large-scale protein manufacturing. E. coli is the most commonly used expression host due to its well-established genomic and sequencing systems, which streamline cloning processes. This makes E. coli the preferred choice in the pharmaceutical sector for protein expression. Additionally, this method enhances the strength of binding in the promoter region, optimizing transcription and further boosting its adoption. These factors collectively contribute to the rapid expansion of the protein expression market.

Restraints in the Global Protein Expression Market

The Protein Expression market faces significant barriers to entry, particularly for new organizations. High costs associated with protein expression reagents and products are inhibiting market growth, while limited awareness of relevant diseases further discourages investment. This issue is especially prominent in developing countries and for smaller companies with constrained budgets. Additionally, the lack of supportive insurance systems in emerging economies is restricting the adoption of advanced eukaryotic expression system products. These challenges are hindering the market's expansion and preventing many potential players from entering the space.

Market Trends of the Global Protein Expression Market

The Protein Expression market is experiencing significant growth driven by the rising demand for biologics used in treating chronic diseases such as cancer, autoimmune disorders, and other serious conditions. Biologics, which include vaccines, blood components, modified medicinal proteins, antibodies, pegylated proteins, hormones, and enzymes, are essential in protein translation. As these biologic therapies continue to expand in demand, the need for protein expression products and services is growing, further propelling the market's development. This trend highlights the crucial role of protein translation in the creation and delivery of innovative biologic treatments.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Analysis

Protein Expression Market, By Product & Service

  • Market Overview
  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services

Protein Expression Market, By System Type

  • Market Overview
  • Mammalian Cell Expression Systems
    • Chinese Hamster Ovary Cell Systems (Cho Cell Systems)
    • Human Embryonic Kidney Cell Systems (Hek 293 Cell Systems)
    • Other Mammalian Cell Systems
  • Prokaryotic Expression Systems
    • Escherichia Coli Systems
    • Other Prokaryotic Expression Systems
  • Insect Cell Expression Systems
    • Baculovirus Systems
    • Other Insect Cell Systems
  • Yeast Expression Systems
    • Pichia Systems
    • Saccharomyces Systems
    • Other Yeast Expression Systems
  • Cell-Free Expression Systems
  • Algal-Based Expression Systems

Protein Expression Market, By Application

  • Market Overview
  • Therapeutic Applications
  • Research Applications
  • Industrial Applications

Protein Expression Market, By End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations & Contract Development & Manufacturing Organizations (CROS & CDMOs)
  • Other End Users

Protein Expression Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genscript Biotech Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Irvine Scientific, Inc. (Acquired by Fujifilm Holdings Corporation) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioneer Corporation (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Expression Technologies Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteogenix (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abeomics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promab Biotechnologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sino Biological, Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jena Bioscience (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifesensors, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leading Biology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peak Proteins (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments